Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Institutional Ownership

Ownership Summary

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) currently has 1 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The collective stake of institutional investors in Shuttle Pharmaceuticals Holdings moved to 0.9% in December 2025, a shift down from the 10.6% reported for September 2025.
• Quarterly data indicates a 149237.50% shift in institutional share volume, and the annual owner count reflects a decrease of 85.71%.
• A review of institutional activity for Shuttle Pharmaceuticals Holdings shows 1 of 1 filers increasing their positions, while 0 reduced their stake, and 0 remained unchanged.
• This class of investors increased its holdings in Shuttle Pharmaceuticals Holdings to 11.95K shares for the 13F-cycle ending December 2025, up by 11.94K shares quarter on quarter, and down 344.71K shares year over year.
• The top institutional stake in Shuttle Pharmaceuticals Holdings as of December 31, 2025 belongs to UBS Group AG, which owns 11.95K shares, or 0.87% of the company.
• Among the most significant buyers of Shuttle Pharmaceuticals Holdings during December 2025 were UBS Group AG (11.94K).
• The top 1 institutional holders of Shuttle Pharmaceuticals Holdings for the quarter ending December 2025 included UBS Group AG (11.95K).